Sign in

CIK 0001761918 · <br>Emerging growth company

Erasca, Inc.

Sign in to watch
Ticker
ERAS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
831217027
Phone
(858) 465-6511
Business address
3115 MERRYFIELD ROW, THIRD FLOOR, SAN DIEGO, CA, 92121
  1. 3 Insider Initial Statement of Ownership
  2. 4 Other acquisition General Counsel & Corp. Sec. acquired 990 shares (other)
  3. 4 Other acquisition Chief Medical Officer acquired 1,562 shares (other)
  4. 4 Derivatives Options or other derivatives
  5. 4 Other acquisition Chief Financial Officer acquired 1,562 shares (other)
  6. 4 Open-market buy Director bought 200,000 shares at $22.10 ($4,420,000)
  7. 4 Open-market buy Director bought 950,000 shares at $16.00 ($15,200,000)
  8. 4 Conversion See Remarks acquired 10,576,417 shares (conversion)
  9. 4 Open-market buy General Counsel bought 900 shares at $16.00 ($14,400)
  10. 4 Conversion Director acquired 900,000 shares (conversion)
  11. 4 Conversion 10% owner acquired 11,055,554 shares (conversion)
  12. 4 Open-market buy Director bought 2,000 shares at $16.00 ($32,000)
  13. 4 Open-market buy Director bought 6,200 shares at $16.00 ($99,200)
  14. 4 Open-market buy Director bought 6,000 shares at $16.00 ($96,000)
  15. 3/A Insider 3/A
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 6 of 7 · 127 filings